Shuttle Pharmaceuticals Holdings, Inc（SHPH）美股招股说明书 S-1 （2025-11-18首版）（英文版）（25页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on November 18,2025 Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHUTTLE PHARMACEUTICALS HOLDINGS,INC.(Exact name of

2、registrant as specified in its charter)Delaware 2834 82-5089826(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)401 Professional Drive,Suite 260Gaithersburg,MD 20879(240)430-4212(Address,including zi

3、p code,and telephone number,including area code,of registrants principal executive offices)Christopher CooperInterim Chief Executive OfficerShuttle Pharmaceuticals Holdings,Inc.401 Professional Drive,Suite 260Gaithersburg,MD 20879(240)430-4212(Name,address,including zip code,and telephone number,inc

4、luding area code,of agent for service)Copies to:David E.Danovitch,Esq.Aaron M.Schleicher,Esq.Sullivan&Worcester LLP1251 Avenue of the Americas,19th FloorNew York,NY 10020(212)660-3060 From time to time after this registration statement becomes effective.(Approximate date of commencement of proposed

5、sale to the public)If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule415 under the Securities Act of 1933 check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)und

6、er the Securities Act,checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following boxand list